CompletedPhase 2NCT02919605

Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Principal Investigator
Anette Talhari, Doctor
Researcher
Intervention
Single dose of Pentamidine(drug)
Enrollment
159 target
Eligibility
16-64 years · All sexes
Timeline
2014 – 2016

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02919605 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials